Author:
Chesnut Charles,Majumdar Sharmila,Gardner J.,Shields A.,Newitt David C.,Erickson E.,Glott M.,Kriegman A.,Mindeholm L.
Reference8 articles.
1. S. R. Cummings, D. M. Black, and T. M. Vogt. Changes in BMD substantially underestimate the anti-fracture effects of alendronate and other antiresorptive drugsJ. Bone Miner. Res.11:s102 (1996).
2. P. D. Delmas, How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?Bone27:1–3. (2000).
3. B. Ettinger, D. M. Black, B. H. Mitlak, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifeneJAMA282:637–645 1999.
4. C. H. Chesnut, S. Silverman, K. Andriano, et al., A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures StudyAm. J. Med.109:267–276 (2000).
5. C. H. Chesnut, Does ultrasound (US) estimate bone quality (BQUAL) or only bone quantity? Data from the QUEST study.J. Bone Miner. Res;15, S529. (2000).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献